Fabienne Staelens

MRI assessment of early response to certolizumab pegol in rheumatoid arthritis: a randomised, double-blind, placebo-controlled phase IIIb study applying MRI at weeks 0, 1, 2, 4, 8 and 16

Mikkel Østergaard, L. Jacobsson, C. Schaufelberger et al. · Annals of the Rheumatic Diseases · 2014 · 35 citations · Full text

Two Dosing Regimens of Certolizumab Pegol in Patients With Active Rheumatoid Arthritis

Daniel E. Furst, Saeed Ahmed Shaikh, Maria Greenwald et al. · Arthritis Care & Research · 2014 · 14 citations · Full text

Effectiveness and safety of certolizumab pegol in rheumatoid arthritis patients in Canadian practice: 2-year results from the observational FαsT-CAN study

Louis Bessette, Boulos Haraoui, Andrew Chow et al. · Therapeutic Advances in Musculoskeletal Disease · 2019 · 11 citations · Full text

Bimekizumab efficacy and safety through 3 years in patients with moderate-to-severe plaque psoriasis: long-term results from the BE RADIANT phase IIIb trial open-label extension period

Richard B. Warren, Mark Lebwohl, Diamant Thaçi et al. · British Journal of Dermatology · 2025 · 10 citations · Full text